Cargando…

Type I IFN deficiency: an immunological characteristic of severe COVID-19 patients

Detalles Bibliográficos
Autores principales:	Wang, Zhenling, Pan, Hailong, Jiang, Boguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487337/ https://www.ncbi.nlm.nih.gov/pubmed/32929061 http://dx.doi.org/10.1038/s41392-020-00306-4

Ejemplares similares

Auto-antibodies against type I IFNs are associated with severe COVID-19 pneumonia
por: Zhou, Weilin, et al.
Publicado: (2021)

Add on the next level—the time point of the type I IFN response orchestrates the immune response
por: Wedekind, Angela, et al.
Publicado: (2020)

Type I interferon signaling deficiency results in dysregulated innate immune responses to SARS‐CoV‐2 in mice
por: Ogger, Patricia P., et al.
Publicado: (2022)

Tumor‐derived microparticles in tumor immunology and immunotherapy
por: Ma, Jingwei, et al.
Publicado: (2020)

Immunological consequences of strain variation within the Mycobacterium tuberculosis complex
por: Tientcheu, Leopold D., et al.
Publicado: (2017)

Potential mechanisms by which impaired ketogenesis links metabolism to T‐cell dysfunction in patients with severe COVID‐19
por: Wang, Bin, et al.
Publicado: (2022)

Make immunological peace not war: Potential applications of tolerogenic dendritic cells
por: Walton, Emma Louise
Publicado: (2017)

Measuring single‐cell protein secretion in immunology: Technologies, advances, and applications
por: Bucheli, Olivia T. M., et al.
Publicado: (2021)

Multiomics uncovers developing immunological lineages in human [Image: see text]
por: Stephenson, Emily, et al.
Publicado: (2021)

The putative mechanism of lymphopenia in COVID-19 patients
por: Wang, Xinling, et al.
Publicado: (2022)

Potential treatment of COVID-19 by inhibitors of human dihydroorotate dehydrogenase
por: Xu, Yechun, et al.
Publicado: (2020)

Mitochondrial Complex I deficiency: guilty in Parkinson’s disease
por: Vos, Melissa
Publicado: (2022)

COVID-19 and Tuberculosis
por: Yang, Heng, et al.
Publicado: (2020)

Combating COVID-19 with Chloroquine
por: Hong, Wanjin
Publicado: (2020)

Single cell RNA and immune repertoire profiling of COVID-19 patients reveal novel neutralizing antibody
por: Li, Fang, et al.
Publicado: (2020)

COVID-19: treating and managing severe cases
por: Ai, Jingwen, et al.
Publicado: (2020)

Experimental and natural infections in MyD88‐ and IRAK‐4‐deficient mice and humans
por: von Bernuth, Horst, et al.
Publicado: (2012)

Genetic tracing of HCoV-19 for the re-emerging outbreak of COVID-19 in Beijing, China
por: Yang, Jing, et al.
Publicado: (2020)

Human-viral chimera: a novel protein affecting viral virulence and driving host T-cell immunity
por: Wang, Zhenling, et al.
Publicado: (2020)

Pandemic number five – Latest insights into the COVID-19 crisis
por: Häfner, Sophia Julia
Publicado: (2020)

The Application of Corticosteroids in COVID-19: A Two-edged Sword
por: Li, Na, et al.
Publicado: (2020)

What we have learned from COVID-19 pandemic?
por: Chen, Hsiu-Hsi, et al.
Publicado: (2021)

Single-cell transcriptomics reveals neuroinflammation in severe COVID-19
por: Lemprière, Sarah
Publicado: (2021)

Prevention and treatment of COVID‐19 disease by controlled modulation of innate immunity
por: Schijns, Virgil, et al.
Publicado: (2020)

Real Nano “Light Vaccine” Will Benefit to COVID-19 Pandemic Control
por: Yang, Jianshe
Publicado: (2021)

Pralidoxime and pesticide poisoning: A question of severity?
por: Walton, Emma Louise
Publicado: (2016)

A next‐generation vaccine for broader and long‐lasting COVID‐19 protection
por: Xi, Jinxiang, et al.
Publicado: (2022)

Neutrophil activation and neutrophil extracellular traps (NETs) in COVID‐19 ARDS and immunothrombosis
por: Cesta, Maria Candida, et al.
Publicado: (2022)

Type I IFN immunoprofiling in COVID-19 patients
por: Trouillet-Assant, Sophie, et al.
Publicado: (2020)

Recent highlights on myocarditis, cardiovascular complications of COVID-19, and cardiomyopathies from the International Journal of Cardiology: Heart & Vasculature
por: Conti, Nicolina, et al.
Publicado: (2022)

“How sad it is! I shall grow old, and horrible, and dreadful” – The ups and downs of cell senescence
por: Kattner, Aila Akosua
Publicado: (2023)

FcγRIIb blockage: a promising immunotherapy target for severe COVID-19
por: He, Xuemei, et al.
Publicado: (2021)

The impact of aging and COVID-19 on our immune system: a high-resolution map from single cell analysis
por: Yang, Jing, et al.
Publicado: (2020)

COVID-19: cross-immunity of viral epitopes may influence severity of infection and immune response
por: Kashir, Junaid, et al.
Publicado: (2021)

COVID-19: complexity of disease severity revealed by systemic and localized single cell immune atlas
por: Alajez, Nehad M.
Publicado: (2021)

Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection
por: Solimani, Farzan, et al.
Publicado: (2021)

Type I interferon signaling and macrophages: a double-edged sword?
por: Adler, Barbara, et al.
Publicado: (2021)

The impact of COVID-19 on cognition in severe cases highlights the need for comprehensive neuropsychological evaluations in all survivors
por: Burdick, Katherine E., et al.
Publicado: (2021)

The role of Syk/CARD9 coupled C-type lectins in antifungal immunity
por: Drummond, Rebecca A, et al.
Publicado: (2011)

Prostaglandin regulation of type 2 inflammation: From basic biology to therapeutic interventions
por: Oyesola, Oyebola O., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p8b35fc4sco7mhibj4qe6tog37